Tema Oncology ETF (CANC) Holdings $25.24 -0.10 (-0.39%) Closing price 08/8/2025 03:33 PM EasternExtended Trading$25.24 0.00 (0.00%) As of 08/8/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Top 25 CANC HoldingsRankCompanyCurrent PriceWeightShares Held1RHHBYRoche$38.23-1.0%4.88%84,4142RVMDRevolution Medicines$35.00+0.1%4.74%85,4813BBIOBridgeBio Pharma$46.58+1.4%4.68%66,6424MRUSMerus$64.00+1.0%4.58%46,4635LLYEli Lilly and Company$625.15-2.5%4.45%4,0446AstraZeneca PLCN/A4.26%19,1417Novartis AGN/A4.12%23,8878GMABGenmab A/S$21.43-5.6%3.81%118,0949SMMTSummit Therapeutics$28.66+2.1%3.80%97,00710NUVLNuvalent$74.11+2.7%3.36%28,819 Get the Latest News and Ratings for CANC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. 11ZLABZai Lab$34.96+2.6%3.29%58,51512ACLXArcellx$70.50-0.9%3.26%30,73713EXELExelixis$37.72+0.9%3.25%60,43214ONCBeOne Medicines$288.18-3.4%3.14%7,00515BMYBristol Myers Squibb$45.96+1.3%3.14%48,80616LEGNLegend Biotech$37.00-1.1%2.99%51,42317AMGNAmgen$288.23+1.2%2.92%6,65418ABBVAbbVie$198.10-0.4%2.71%9,62519IDYAIDEAYA Biosciences$23.10+3.1%2.29%63,21420MRKMerck & Co., Inc.$80.73+0.4%2.13%18,37321IMNMImmunome$9.69-1.8%1.64%104,68522JANXJanux Therapeutics$22.83+1.1%1.62%45,42123Daiichi Sankyo Company, LimitedN/A1.56%42,48524COGTCogent Biosciences$10.96+0.9%1.44%84,77125ARGXargenex$661.83-1.6%1.40%1,404 Geographic ExposureUnited States167.5%Netherlands8.8%United Kingdom8.4%Switzerland8.3%Japan5.9%Israel0.9%Currency ExposureUSD177.3%GBP8.4%CHF8.3%JPY5.9%Sector ExposureHealth Care194.9%Consumer Discretionary1.2%Information Technology0.9%Industry ExposureBiotechnology181.3%Pharmaceuticals10.7%Diversified Consumer Services3.3%IT Services0.9%Health Care Equipment & Supplies0.8%SubIndustry ExposureBiotechnology155.1%Pharmaceuticals26.6%Internet Services & Infrastructure0.9%Life Sciences Tools & Services0.8%Coupon Exposure4-60.5%Maturity Exposure15-200.5% Related Companies and Tools Related Companies SPDR Galaxy Hedged Digital Asset Ecosystem ETF Portfolio Companies Global X E-Commerce ETF Portfolio Companies Spear Alpha ETF Portfolio Companies Xtrackers Artificial Intelligence and Big Data ETF Portfolio Companies AOT Growth & Innovation ETF Portfolio Companies Sprott Critical Materials ETF Portfolio Companies Global X Aging Population ETF Portfolio Companies Roundhill Daily 2X Long Magnificent Seven ETF Portfolio Companies RockCreek Global Equality ETF Portfolio Companies REX Crypto Equity Premium Income ETF Portfolio Companies This page (NASDAQ:CANC) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CANC Stock Alerts